Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (2), 175-180
- https://doi.org/10.1016/s0168-8278(05)80055-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1988
- The development of cirrhosis in patients with chronic type B hepatitis: A prospective studyHepatology, 1988
- HLA Class i antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitisHepatology, 1987
- Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant α-interferonHepatology, 1987
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infectionGastroenterology, 1987
- Early detection of hepatocellular carcinoma in patients with chronic type B hepatitisGastroenterology, 1986
- Natural History of Chronic Hepatitis B Virus Infection in Taiwan: Studies of Hepatitis B Virus Dna in SerumHepatology, 1985
- Determinants for hepatitis B e antigen clearance in chronic type B hepatitisLiver International, 1984